Avanos Medical AVNS Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's increase (decrease) in accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Avanos Medical's increase (decrease) in accounts receivable?
- Avanos Medical (AVNS) reported increase (decrease) in accounts receivable of $300K in Q1 2026.
- How has Avanos Medical's increase (decrease) in accounts receivable changed year-over-year?
- Avanos Medical's increase (decrease) in accounts receivable increased by 101.2% year-over-year, from -$25.1M to $300K.
- What does increase (decrease) in accounts receivable mean?
- Tracks the net change in amounts owed to the company by customers for goods or services delivered on credit. An increase typically indicates rising sales or potential collection delays, while a decrease suggests improved cash conversion efficiency.